Many patients modifying medication dosage forms without professional advice
the ONA take:
According to a new study published in the Journal of Pharmacy Practice and Research, researchers from Queensland University of Technology and the University of Queensland in Queensland, Australia, have found that people who take more than four doses of medication each day are more likely to crush tablets or open capsules, thereby possibly decreasing their effectiveness.
Results of the study showed that 44.2% of the 369 respondents believed there would be no issues with crushing tablets or opening capsules.
Researchers also found that 14% said they have trouble swallowing capsules or tablets and that people modified their medicine despite no issues with swallowing. In addition, 10% of respondents reported modifying their medication regardless of how many doses they took each day.
Although the findings found that many participants said they would not ask for advice before modifying their medications or inform their healthcare professional of problems swallowing, previous research has found that healthcare professionals are not asking their patients about swallowing difficulties often enough.
People who take more than four doses of medication each day are more likely to crush tablets or open capsules.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|